January 3, 2017 / 12:22 PM / 8 months ago

Inotek's treatment for glaucoma misses main goal in late-stage study

Jan 3 (Reuters) - Inotek Pharmaceuticals Corp said on Tuesday that its treatment for glaucoma did not meet its main goal in the first pivotal late-stage study.

The company said the main goal of superiority was not achieved over a placebo.

Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Maju Samuel

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below